Archives
-
Biotin-XX Tyramide Reagent for Cell-Surface TSA
2026-09-01
Biotin-XX Tyramide Reagent combines HRP-driven amplification with membrane-impermeant labeling, making it useful for low-abundance surface proteins, neuronal proximity maps, IHC, and ISH. Its practical advantage is selectivity at the cell boundary, but serotonin-dependent inhibition and reagent handling can determine whether the assay succeeds.
-
Calpain Inhibitor II, ALLM in FAK Proteolysis
2026-09-01
Calpain Inhibitor II, ALLM provides a cell-permeable way to interrogate calpain- and cathepsin-dependent proteolysis. This article connects its target profile with FAISL-regulated FAK cleavage in TNBC and translates that mechanism into more rigorous apoptosis and protease inhibition assays.
-
LINC02870, EIF4G1, and SNAIL in HCC Progression
2026-08-31
The reference study identifies LINC02870 as a potentially oncogenic lncRNA that promotes hepatocellular carcinoma progression by engaging EIF4G1 and enhancing SNAIL translation. Its combination of public-dataset analysis, clinical samples, cellular phenotyping, and mechanistic investigation provides a framework for studying lncRNA control of translation, while follow-up RNA-protein assays are still needed to establish direct molecular interactions.
-
Perifosine: From Akt Biology to Translational Strategy
2026-08-31
Perifosine, also known as KRX-0401, is more than an Akt inhibitor: it is a context-sensitive research tool for connecting survival signaling, apoptosis, and radiation response. This thought-leadership guide translates oncology evidence and PI3K/Akt/mTOR insights from cerebral ischemia research into a disciplined strategy for translational study design.
-
EdU Imaging Kits (Cy5): PH Research Workflow
2026-08-30
EdU Imaging Kits (Cy5) convert S-phase DNA synthesis into a sensitive far-red readout for microscopy and flow cytometry. This guide translates a pulmonary hypertension exosome study into practical proliferation workflows while emphasizing controls, assay boundaries, and troubleshooting.
-
AZ505 and the Translational Logic of SMYD2 Inhibition
2026-08-29
AZ505 offers a mechanistically defined way to interrogate SMYD2 biology beyond catalytic potency alone. By connecting substrate-competitive inhibition with findings in cisplatin-induced renal fibrosis, this article outlines an assay-first strategy for epigenetic regulation research, cancer biology research, and translational model development.
-
Cy5 RNA Probes for Translational TREM2 Research
2026-08-28
A thought-leadership guide to using tunable Cy5-labeled RNA probes to interrogate TREM2 biology, macrophage efferocytosis, and inflammatory disease models. The article connects mechanistic findings on cleavage-resistant TREM2 with practical strategies for probe design, assay validation, and translational decision-making.
-
Why Cap 1 Matters for Translational mRNA Assays
2026-08-28
A thought-leadership perspective on how Cap 1 chemistry, poly(A) design, and reporter assay discipline can turn luciferase mRNA into a translational instrument for evaluating delivery, expression, and formulation performance.
-
Chemically Modified SOD2 mRNA for Renal IRI
2026-08-27
The reference study identifies SOD2 as an enriched protein in mesenchymal stem cell-derived extracellular vesicles and tests a defined lipid nanoparticle system for delivering chemically modified SOD2 mRNA. In cultured cells and an ischemia-reperfusion mouse model, this strategy reduced oxidative stress and renal injury, supporting mitochondrial ROS modulation as a mechanistically informed approach to acute kidney injury research.
-
NHS-Biotin for Nanobody Assembly and Detection
2026-08-27
NHS-Biotin converts primary-amine chemistry into a practical route for tracking, capturing, and comparing monomeric versus multimeric nanobodies. This guide connects amine-reactive labeling with peptidisc-assisted polybody workflows, emphasizing reproducible setup, accessible assay readouts, and troubleshooting.
-
Dual Recombinase Tracing Finds No Mouse Neo-oogenesis
2026-08-26
Xie, Zhou, and Zheng combined Cre-loxP and Dre-rox lineage tracing to test whether postnatal ovarian cells generate new oocytes in mice. Across physiological aging and busulfan-induced ovarian injury, the study detected no labeled growing oocytes or metaphase II eggs, strengthening the conclusion that in vivo postnatal neo-oogenesis is not measurably active under the tested conditions.
-
Sulfo-NHS-SS-Biotin: Practical Labeling Guide
2026-08-26
Sulfo-NHS-SS-Biotin provides water-compatible, amine-reactive labeling for proteins and accessible primary amines on intact cell surfaces, with a disulfide linker that supports reductive release. It is suitable for protein labeling, affinity capture, and protein purification workflows, but should not be used in amine-containing reaction buffers or assumed to label intracellular proteins in intact cells.
-
FLCN Mutations and mRNA Rescue in BHD Syndrome
2026-08-25
A 2026 study identified a novel pathogenic FLCN nonsense variant and provided segregation and functional evidence supporting reclassification of p.W376R in two Chinese Birt-Hogg-Dubé families. In HEK293T cells, synthetic FLCN mRNA restored folliculin expression and corrected mTORC1 dysregulation, offering preliminary—not yet clinical—support for an mRNA replacement strategy.
-
EZ Cap™ Firefly Luciferase mRNA: Lab Q&A
2026-08-25
This scenario-driven guide explains how EZ Cap™ Firefly Luciferase mRNA, SKU R1018, can improve the interpretability of delivery, translation, viability, and cytotoxicity workflows. It combines product specifications with practical controls, handling guidance, and carefully bounded evidence from recent mRNA delivery research.
-
ddhCTP: Mechanism-Aware Antiviral Assays
2026-08-24
ddhCTP is more than a chain-terminating antiviral nucleotide analog: it is a mechanistic probe for separating direct RdRp inhibition from broader viperin activity. This guide shows how to design and interpret biochemical, cellular, and coronavirus-focused assays without conflating distinct antiviral pathways.